ArticleFrontiers in immunology2022

Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma.

Shun-Li Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.